Pim2 is a serine/threonine kinase expressed at high levels in several malignancies including acute leukemia. Pim2 protein is induced by oncogenic Fms-like tyrosine kinase-3 (Flt3)-internal tandem duplications (ITD), but not by Flt3 wild-type receptor (Flt3-Wt) in response to Flt3 ligand (FL). Here we show that Pim2 can complement Flt3-Wt signaling and induce transformation similar to Flt3-ITD in myeloid cells. Our data demonstrate that Pim2 is necessary but not sufficient for Flt3-ITD-induced transformation of 32D cells and primary bone marrow cells as assessed by colony assays. Pim2-induced clonogenic growth of FL-treated 32D-Flt3-Wt cells. Proliferation of 32D-Flt3-Wt cells was significantly enhanced in FL-treated Pim2-overexpressing cells. This increase was associated with enhanced Sphase cell cycle progression. Pim2-overexpressing cells were resistant to apoptosis induced by growth factor deprivation or treatment with tyrosine kinase inhibitor (PKC412). The Flt3 point mutant D835Y, which is not able to support colony growth of myeloid cells, also induced clonogenic growth in the presence of Pim2. In conclusion, Pim2 is an important target of Flt3-ITD-induced transformation, and overexpression of Pim2 together with Flt3-Wt or D835Y receptor mimics Flt3-ITDmediated transformation. Pim2 complements with Flt3-Wt signaling to induce proliferation by enhancing G 1 /S-phase progression of the cell cycle.
Introduction
Flt-3 (Fms-like tyrosine kinase-3) is a receptor tyrosine kinase expressed by hematopoietic progenitor cells. Its activity is essential for normal blood development and establishment of the immune system. 1 Mutations of the Flt3 gene have been reported in patients with acute myeloid leukemia (AML). The majority of these patients harbor internal tandem duplications (ITD) in the sequence encoding the juxtamembrane domain of the Flt3 receptor. These ITD mutations occur in approximately 30% of patients with AML. 1 We and others have shown that Flt3-ITD mutations induce transformation of myeloid cells in vitro and in vivo and Flt3-ITD mutations activate signaling pathways that are very similar to interleukin (IL)-3-induced signaling events. [2] [3] [4] The serine-threonine kinase Pim2 is transcriptionally induced by both Flt3-ITD and IL-3. [4] [5] [6] The second type of Flt3 mutation, reported in about 7% of AML patients, is an activating point mutation in the tyrosine kinase domain of the receptor (TKD) and often involves mutation of an aspartate to a tyrosine residue at position 835 (D835Y). 1 These mutations result in ligand-independent activation of the receptor. 7 Recently, we and others have described differences in the signaling properties of Flt3-ITD and Flt3-TKD mutations in liquid culture. 8, 9 While both mutations confer growth factor independence to myeloid cells, only Flt3-ITD is capable of transforming these cells as demonstrated by clonogenic assays. Thus, TKD mutations behave similarly to Flt3 wild-type receptor (Flt3-Wt) in the presence of its Flt3 ligand (FL). 2, 8 The Pim family of proto-oncogenes (Pim1, Pim2 and Pim3) encodes serine threonine kinases that are widely expressed in the hematopoietic system. 10 Transcription of Pim1 and Pim2 is induced by a wide variety of growth factors via STAT5 activation. 6, 11, 12 Pim1 and Pim2 are shown to protect hematopoietic cells from cell death, and deficiency of Pim kinases leads to reduced body size in knockout mouse studies. 10, [13] [14] [15] [16] [17] Interestingly, when primary bone marrow-derived blast cells from patients with AML were assessed for Pim2 expression using quantitative RT-PCR, many AML patients showed overexpression of Pim2 regardless of the presence of Flt3-ITD mutations. 2 This suggests that Pim2 expression may be increased by mechanisms other than Flt3-ITD and points to a role for Pim2 in the pathogenesis of AML.
While Pim2 is important for Flt3-ITD-mediated transformation of 32D cells, Flt3-D835Y-activating point mutations or FLstimulated Flt3 wild-type receptor do not induce Pim2 expression and are not sufficient to support transformation of myeloid cells. 4, 8 Therefore, we hypothesized that Pim2 coexpression in 32D cells expressing Flt3-Wt or Flt3-TKD can induce transformation of these cells.
Here we show that Pim2 overexpression in 32D Flt3-Wt cells enhances proliferation by enhancing S-phase entry and induces transformation by synergizing with Flt3.
Materials and methods

Reagents
Recombinant human FL and recombinant murine IL-3 were purchased from PeproTech (Rocky Hill, NJ, USA). The antibodies for anti-Pim2, anti-CCAAT/enhancer-binding protein-a (C/EBPa), anti-PU.1, anti-STAT5a/b from Santa Cruz Biotechnology (Santa Cruz, CA, USA), anti-phospho STAT5a/b antibody from Upstate Biotechnology (Lake Placid, NY, USA) and the mouse monoclonal anti-actin antibody were purchased from Sigma (Taufkirchen, Germany). Anti-BrdU FITC-conjugated antibody kit was purchased from Becton and Dickinson (NJ, USA).
Cell lines
The IL-3-dependent murine myeloid cell line 32Dcl3 (kindly provided by Dr Felicitas Rosenthal, Freiburg, Germany) was cultured in RPMI 1640 supplemented with 10% Walter and Eliza Hall Institute-3 (WEHI3 cell)-conditioned medium as a source of IL-3, 10% fetal calf serum (FCS), 1% penicillin/ streptomycin and 1% L-glutamine. Cells were cultured in a humidified incubator at 37 1C with 5% CO 2 .
Generation of stable 32D cell lines
Stable cell lines (32D-Flt3-Wt or Flt3-D835Y) were generated essentially as described.
8 32D-Flt3-Wt or Flt3-D835Y cells overexpressing Pim2 were generated by transduction with retroviral supernatants collected from Phoenix packaging cells transfected with Pinco-Pim2 or Pinco empty vector control. 18 green fluorescent protein (GFP)-positive cells were sorted by flow cytometry. Pim2 expression was analyzed in these stable cell lines by western blotting.
Western blot analyses
Western blots were performed as described before. 19 Immunoblots were incubated with antibodies against Pim2, C/EBPa, PU.1 pSTAT-5, tSTAT-5, SOCS 1 or actin (Sigma) followed by incubation with secondary immunoglobulin G antibody conjugated with horseradish peroxidase.
H-thymidine incorporation
A total of 2 Â 10 4 32D Flt3-Wt cells over expressing Pim2 were deprived of IL-3 and serum (0.5%. FCS) for 12 h in 200 ml medium in 96-well plate. Subsequently, cells were placed in medium with 10% FCS and supplemented with the indicated concentrations of FL. After an 8-h incubation period at 37 1C, 1 mCi (0.037 MBq) 3 H-thymidine was added to each well, and cells were incubated for additional 12 h. Cells were harvested onto glass fiber filters, and emission of bound DNA was analyzed in a scintillation counter.
Clonal growth in methylcellulose
Colony assays with stable cell lines were performed as described before. 8 Colony assays after transient transfection were performed by electroporating and seeding these cells 24 h later in methylcellulose with 20% FCS and 2 ng ml À1 IL-3 and G 418 (0.6 mg ml
À1
). Colonies were counted between days 8 and 11.
Transduction of mouse hematopoietic progenitor cells and colony assays
Bone marrow cells were harvested and colony assays were performed as described earlier. 20 Cells were transduced with retroviral supernatants collected from Phoenix packaging cells transfected with Pinco-Pim2 or Pinco empty vector control. 18 Transduced cells were cultured for 2 days and sorted for GFPpositive cells. One thousand GFP-positive sorted cells were seeded in methylcellulose supplemented with IL-3, stem cell factor and IL-6. After 10 days, colonies were collected from methylcellulose and replated (5000 cells per dish) on fresh methylcellulose medium with supplements mentioned above. Remaining cells from the colony assay were used for western blot to analyze the expression of Pim2.
For differentiation analyses GFP-positive cells were cultured in the presence or absence of granulocyte colony-stimulating factor (GCSF) (50 ng ml À1 ). Smears were prepared and stained by Wright-Giemsa staining. Surface expression of CD11 b was analyzed by flow cytometry after staining with anti-CD11b-PEconjugated antibody. The percentage of GFP and CD11b-PE double-positive cells were assessed.
Apoptosis assay
Briefly, 32D Flt3-Wt or D835Y cells expressing Pim2 or empty vector constructs were seeded in RPMI medium containing FCS alone or FL (20 ng ml À1 ) in combination. Cells were incubated with PKC412 at 50 nM final concentration. At indicated time points cells were stained with annexin V-PE and 7ADD following the manufacturer's instructions (Immunotech, Marseille, France). Double-positive cells were analyzed by flow cytometry using a FACSCalibur cytometer (Becton Dickinson, NJ, USA).
Detection of BrdU incorporation into DNA-synthesizing cells
Cell cycle analyses were performed by BrdU incorporation assay with propidium iodide staining. Stable 32D-Flt3-Wt cells expressing Pim2 were IL-3 starved and serum deprived (0.5% FCS) for 12 h. Subsequently, cells were stimulated with FL (20 ng ml À1 ) and harvested at different time points after stimulation. Cells were pulsed with BrdU (10 mM) 1 h before each harvest. Next, cells were stained with FITC-conjugated anti-BrdU antibody following the manufacturer's instructions. Briefly, cells were fixed in ethanol followed by denaturation and antibody incubation. Isotype controls were used. Cells were washed and incubated with propidium iodide (50 mg ml À1 ) for 30 min in the dark. Subsequently, DNA content (PI) and DNA synthesis (FITC-BrdU) were assessed by flow cytometry using a FACSCalibur cytometer (Becton Dickinson).
siRNA for Pim2
To generate short hairpin RNAs (shRNA) for Pim2 RNAi, Pim2 siRNA sense and antisense (Eurogentec, Kö ln, Germany), oligos were annealed and cloned into p-super vector (Oligoengine, WA, USA). Sequences of oligos cloned into pSuper vector were AAGGCTTCATGCTGGTCCTFoligo1 sense, AGGACCAGCAT GAAGCCTTFoligo1 antisense, AAGGATGAGAACATCCTGAF oligo2 sense and TCAGGATGTTCTCATCCTTFoligo2 antisense. Clones were confirmed by sequencing. 32D Flt3-ITD cells were electroporated with 16 mg of Pim2 shRNA (1 and 2) together with pcDNA3 in a ratio of 5:1, in order to select the transfected cells with G 418 antibiotic in colony assays. After 24 h cells were washed once and used for colony assay in methylcellulose in the presence of G 418 . Expression of Pim2 in these cells was analyzed by western blot analysis.
Results and discussion
Pim2 is required for Flt3-ITD-mediated cellular transformation resistance gene. Colony assays were performed in the presence of G 418 to select for the transfected cells. The number of clonogenic cells was decreased threefold in cells that were transfected with shRNA against Pim2 as compared with controltransfected cells (Po0.01) (Figure 1a ). Pim2 protein levels were reduced 12-fold in Pim2-shRNA-transfected cells compared to the control-transfected cells (Figures 1b and c) .
The finding that inhibition of colony growth was not complete could be due to the fact that Pim2 protein levels were not entirely abolished. Alternatively, other Pim family members, such as Pim1, may have partially substituted for Pim2 to cause residual colony growth. In fact, Pim1 protein is expressed in 32D cells, but Pim2 shRNA did not affect Pim1 expression (data not shown). These data confirm and extend previous observations showing that a loss-of-function mutant of Pim2 or siRNA against Pim2 significantly inhibited colony growth of 32D-Flt3-ITD or Ba/F3-ITD cells, respectively. 4, 21 We do not rule out the possibility that Pim1 might compensate the effect of Pim2 in ITD cells. However, Adam et al. 21 have shown that Pim1 knockdown using siRNA or suppression of Pim1 activity by using a kinase dead mutant of Pim1 does not significantly inhibit the growth of transformed cell lines, whereas Pim2 alone significantly inhibits the growth of these cells. Here in the present report, we used shRNA to inhibit Pim2 expression and show that Flt3-ITD-mediated transformation is partially dependent on Pim2. 4, 21 Further experiments are necessary to conclude if one member of the Pim family plays a dominant role over the other in Flt3-ITD-mediated transformation.
Pim2 overexpression synergizes with FL to stimulate proliferation
In order to analyze the potential of Pim2 to complement Flt3 wild-type receptor signaling, we established stable cell lines by retroviral transduction of 32D Flt3 wild-type receptor-expressing cells with Pim2. Expression of Pim2 in stable cells was analyzed in the absence of IL-3, since IL-3 can induce Pim2 expression. As shown in Figure 2a , Pim2 was expressed at high levels in the stable cells, whereas Pim2 protein was not detectable in cells transduced with vector alone. FL stimulation had no effect on Pim2 expression, and expression of the close homologue Pim1 was not altered in Pim2-overexpressing cells (data not shown).
32D cells are dependent on IL-3 for their growth, and expression of Flt3-Wt in these cells allows to substitute IL-3 by FL. 2, 22 To analyze the effect of Pim2 overexpression on proliferation, we performed 3 H thymidine assays on 32D-Flt3-WT cells in the absence or presence of FL. In the absence of growth factors, Pim2-overexpressing cells showed basal proliferation (data not shown), whereas control 32D-Flt3-WT cells that had been transfected with empty vector instead of Pim2 readily underwent apoptosis and did not proliferate. Interestingly, in the presence of increasing doses of FL, Pim2 overexpression consistently enhanced proliferation, when compared to vector control. Overall, Pim2 overexpression synergized with Flt3 signaling, while Pim2 alone only had minor effects on 32D cell proliferation (Figure 2b) .
To assess the effects of Pim2 overexpression on cell cycle progression, we analyzed BrdU incorporation in response to FL stimulation at different time points in serum and IL-3 -deprived 32D-Flt3-Wt cells. Pim2 cells did not arrest entirely in G 1 phase of the cell cycle after 10 h of starvation, and a significantly higher fraction of the cells were in late S phase as compared to control cells (Figure 2c ). Starvation time of 10 h may not be sufficient to arrest all 32DFlt3-Wt-Pim2-expressing cells in G 1 phase, whereas most of the 32DFlt3-Wt control cells were arrested in G 1 phase (Figure 2c ).
After stimulation with FL, Flt3-Wt and Pim2-overexpressing Flt3-Wt cells rapidly entered S-phase (Figures 2c and d) . However, a significantly higher fraction of Pim2-positive cells entered S-phase than control cells. The percentage of cells in S phase was consistently higher in Pim2-overexpressing cells over the whole time course as compared to control cells (Figures  2c and d) . This required Pim2 kinase activity, since the kinaseinactive mutant of Pim2 was unable to stimulate S-phase entry and showed similar results as empty vector cells (Figure 2d ). Pim proteins have been suggested to play an important role in growth and proliferation, and a stimulatory role for cell cycle progression has been demonstrated for Pim1. 10, 13, [23] [24] [25] [26] [27] In the present paper, we provide evidence that Pim2 enhances S-phase entry. These results indicate that Pim2 functions as an active kinase in regulating cell cycle progression during G 1 /S-phase transition. Involvement of Pim1 in the cell cycle as a positive regulator at G 2 /M transition has been described before, where Pim1 phosphorylates and inhibits the activity of the cell cycle inhibitor C-TAK1. 28 Moreover, Pim1 was demonstrated to directly bind to, phosphorylate and activate CDC25A, a phosphatase, which positively regulates G 1 /S-phase transition of the cell cycle. 27 Also, Pim1 led to phosphorylation and inactivation of the cell cycle inhibitor, p21 cip1/waf1 , and it was shown to be involved in mitosis. 29, 30 Our finding that Pim2 can Pim2 in leukemic transformation S Agrawal et al enhance G 1 /S-phase progression in cooperation with FL is intriguing and provides a mechanism of how Pim2 may confer a proliferative advantage to these cells. The search for potential cell cycle regulators whose activity is modified by Pim2 is warranted. Currently, we are analyzing the interacting partners of Pim2 by a systematic approach yeast-two-hybrid screen.
Pim2 confers resistance toward apoptosis
Next, we analyzed the antiapoptotic effects of Pim2 on 32D-Flt3-Wt or Flt3-D835Y cells. We compared the proportion of Flt3-Wt or Flt3-D835Y cells undergoing apoptosis after growth factor withdrawal in the presence or absence of Pim2 at several time points. In the absence of growth factors and Pim2, 50% of 32D-Flt3-Wt cells underwent apoptosis within 48 h. In contrast, Pim2 alone could rescue a significant fraction of cells under these conditions (Figure 3a) . No significant apoptosis was observed in Flt3-D835Y cells independent of Pim2 expression under growth factor-deprived conditions, which is comparable to Flt3-ITD (Figure 3a) . Furthermore, we compared the effects of tyrosine kinase inhibitor (PKC412) on apoptosis induction in Flt3-Wt and Flt3-D835Y cells in the presence or absence of Pim2. We incubated 32D Flt3-Wt or Flt3-D835Y cells containing either Pim2 or vector alone and Flt3-ITD cells with PKC412 (50 nM) and analyzed the extent of apoptosis at the indicated time points (Figure 3b ). Similar to Flt3-ITD cells, Pim2-overexpressing 32D Flt3-Wt cells were more resistant to PKC412-induced apoptosis than 32D Flt3-Wt control cells. Similarly in the presence of Pim2, B70% of the Flt3-D835Y cells survived the treatment, whereas only B30% of Flt3-D835Y cells without Pim2 were rescued from PKC412-induced apoptosis. Addition of FL to PKC412 rescued the cells from apoptosis to some extent (Figure 3c ). Similar findings were observed when apoptosis was induced by UV irradiation of cells in the presence or absence of FL (data not shown). Taken together, these data indicate that Pim2 alone induced significant antiapoptotic effects (Figure 3a ) that were moderately enhanced by FL (Figure 3c ) and strongly by Flt3-D835Y (Figures  3b and c) , whereas, for inducing proliferation it cooperates with Flt3 receptor.
Pim2 induces transformation of Flt3 wild-type or Flt3-D835Y overexpressing 32D cells and of primary murine bone marrow cells
Having shown that Pim2 is necessary for Flt3-ITD-induced colony growth and that it can complement the antiapoptotic and proliferative signals of Flt3-WT, we investigated whether Pim2 also alters clonogenic growth of 32D-Flt3-WT cells. As shown previously, 32D-Flt3-WT cells were not able to form colonies even in the presence of FL. 2 Interestingly, Pim2 overexpression was sufficient to induce clonogenic growth of Flt3-Wt expressing cells in the presence of FL. Notably, to fully exert this function, Pim2 needed additional signals that could be provided 
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by FL or IL-3, but not by serum alone (Figure 4a) . Thus, our data strongly point to the notion that wild-type Flt3 and Pim2 provide overlapping yet distinct signals toward proliferation and survival that synergize to result in a signal toward leukemic transformation resembling that of Flt3-ITD. Our data indicate that wildtype Flt3 and Pim2 are largely redundant in providing antiapoptotic signals (Figure 3) . Previously, we and others have shown that Flt3-dependent survival signals are primarily mediated by activation of the PI3K-AKT pathway. 8, 31 Indeed, both Pim2 and Akt are known to phosphorylate the antiapoptotic protein BAD, 15, 16 suggesting that both pathways impinge on apoptosis regulation through modification of the Bcl2 family of proteins. Overexpression of Pim2 did not enhance the activity of AKT in our experiments (data not shown), as has been described previously. 15 More evidence for the hypothesis that Pim2 and AKT are components of overlapping but yet independent pathways comes from studies by Hammerman et al. 32 using
Pim1 and Pim2 knockout mice. These authors showed that Pim2 is required for cell growth and survival when the AKT pathway is pharmacologically inhibited by rapamycin. 32 Likewise, overexpression of either Pim2 or AKT led to increased cell size and resistance against apoptosis. Interestingly, coexpression of both Pim2 and AKT transgenes in mice induced the formation of lethal lymphomas in all double-transgenic animals, while none of the Pim2 single-transgenic mice and only one out of ten AKT single-transgenic mice developed lymphoma. 32 In our study, we show that Pim2 acts synergistically with Flt3-Wt to induce transformation. This could be due to stabilization of the effect of AKT on cell survival and proliferation via an independent but parallel pathway.
Expression of an activating point mutation of Flt3 receptor, D835Y, in myeloid cell lines and in primary bone marrow induced a significantly different phenotype than Flt3-ITD and, Flt3-ITD induces a myeloproliferative syndrome in a 
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S Agrawal et al retroviral transplantation model of primary mouse bone marrow, while Flt3-D835Y did not. 9 A good surrogate parameter for the differential transforming potential of these mutations was their ability to induce clonogenic growth of 32D cells in semisolid media. While Flt3-ITD-induced colony growth in 32D cells, Flt3-D835Y (like Flt3-WT in the presence of FL) did not. 8 To investigate whether Pim2 can confer clonogenic growth properties to 32D-Flt3-D835Y cells, we established a stable cell line by retrovirally transducing Pim2 into 32D-Flt3-D835Y cells. When we analyzed the colony growth of these cells in semisolid media in the presence or absence of FL, we observed that Flt3-D835Y cells overexpressing Pim2 were now able to form colonies, regardless of the presence of FL (Figure 4b) . 8 Stable high expression of Pim2 was confirmed by western blot in these cells (Figure 4c) . Obviously, Pim2 complements signals provided by Flt3-WT or Flt3-D835Y to resemble the transforming capacity of Flt3-ITD (Figure 4d) .
In order to confirm our findings in primary cells, a bone marrow colony assay was performed. Pim2 expression significantly enhanced colony growth of primary mouse bone marrow as compared to control (Po0.01) (Figure 4e ). Pim2 overexpression in these colonies was confirmed by western blotting (Figure 4f ). We also seeded Pim2-transduced bone marrow cells in colony assays in the absence of growth factors to analyze whether Pim2 can provide growth factor independence to primary progenitor cells as shown for Flt3-ITD. However, we did not observe any colony growth under these conditions (Figure 4e ). These data show that Pim2 alone is not able to confer growth factor independence. Pim2 did not alter the replating efficiency of colonies as compared to empty vector (data not shown).
Transforming potential of Pim2 is independent of differentiation
We wanted to further investigate whether the growth advantage induced by Pim2 in Flt3-Wt cells was associated with a disruption of myeloid differentiation and/or expression of C/EBPa and PU.1 as has been described for Flt3-ITD. 4 ,33 (Figures 5b and c) .
Thus, it appears that while Pim2 may confer many of the growth-stimulatory effects of Flt3-ITD, other pathways are responsible for the Flt3-ITD-mediated differentiation block. It will be interesting to dissect these pathways and identify further specific targets of Flt3-ITD that may enhance the differentiation block in patients with AML.
Transforming potential of Pim2 in D835Y cells is independent of STAT5 activation
We observed strong antiapoptotic and transforming effects of Flt3-D835Y cells in the presence of Pim2. As described previously, Flt3-D835Y induces very weak activation of STAT5. 8 We analyzed whether Pim2 induces STAT5 activation in these cells. We compared STAT5 activation in Flt3-D835Y cells expressing Pim2 or empty vector alone in the presence of the indicated growth factors (Figure 5d ). STAT5 was very weakly activated in D835Y cells in the presence of FL or FCS alone compared to IL-3 ( Figure 5d ). Pim2 overexpression in D835Y cells did not enhance STAT5 activation in all three conditions, while Flt3-ITD cells harbored strong STAT5 phosphorylation regardless of Pim2 expression (Figure 5d ). We also analyzed SOCS1 expression levels in Pim2-overexpressing 32D-D835Y cells since Pim and SOCS family proteins function as components of negative feedback mechanism to regulate STAT5 activity. 34 Pim2-mediated phosphorylation of SOCS1 would be expected to stabilize SOCS1 levels in the cell. 35 Here no change in the SOCS1 levels were observed in response to Pim2 overexpression in 32D-Flt3 D835Y cells (Figure 5d ). These data suggest that Pim2-induced transformation of 32D D835Y cells is independent of its influence on the upstream SOCS1/STAT5 pathway. Rather, alternative pathways such as altered cell cycle regulation or inhibition of apoptosis by Pim2 could be responsible for this transformation.
Taken together, our findings suggest that Pim2 and Flt3 act through different but complementary pathways to stimulate cell cycle progression and inhibit apoptosis. Together, they can transform hematopoietic progenitor cells similar to Flt3-ITD. Thus, Pim2 may be an interesting target for novel specific antileukemic therapies. Total cell lysates were separated by SDS-PAGE and blots were probed with antibody specific for phospho STAT5 (Y694/699). Blots were striped and reprobed with total STAT5 antibody followed by SOCS1 and actin antibodies.
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